KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 321,346 Value ($000) $6,543 Avg Close $17.54 Range $13.60 - $22.55

Q3 2025

Shares 335,154 Value ($000) $5,302 Avg Close $14.77 Range $13.13 - $16.30

Q2 2025

Shares 265,707 Value ($000) $3,547 Avg Close $13.50 Range $9.12 - $15.40

Q1 2025

Shares 128,103 Value ($000) $1,305 Avg Close $11.61 Range $9.71 - $16.70

Q4 2024

Shares 29,146 Value ($000) $461 Avg Close $51.97 Range $15.33 - $72.37

Q3 2022

Shares 9,620 Value ($000) $362 Avg Close $34.66 Range $26.34 - $42.15

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	321,346	$6,543	$17.54	$13.60 - $22.55
Q3 2025	335,154	$5,302	$14.77	$13.13 - $16.30
Q2 2025	265,707	$3,547	$13.50	$9.12 - $15.40
Q1 2025	128,103	$1,305	$11.61	$9.71 - $16.70
Q4 2024	29,146	$461	$51.97	$15.33 - $72.37
Q3 2022	9,620	$362	$34.66	$26.34 - $42.15